Disulfiram: A Proven Pharmacological Deterrent for Alcohol Dependence
| Product dosage: 60mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.37 | $41.20 (0%) | 🛒 Add to cart |
| 60 | $1.11 | $82.39 $66.32 (20%) | 🛒 Add to cart |
| 90 | $1.02 | $123.59 $91.44 (26%) | 🛒 Add to cart |
| 120 | $0.98 | $164.79 $117.56 (29%) | 🛒 Add to cart |
| 180 | $0.94 | $247.18 $168.80 (32%) | 🛒 Add to cart |
| 270 | $0.90 | $370.77 $244.16 (34%) | 🛒 Add to cart |
| 360 | $0.88
Best per pill | $494.36 $318.52 (36%) | 🛒 Add to cart |
Synonyms | |||
Disulfiram is an established alcohol-aversion therapy medication, functioning as a cornerstone in the pharmacological management of chronic alcohol use disorder. Its unique mechanism of action provides a powerful psychological and physiological deterrent against alcohol consumption, supporting long-term sobriety goals when integrated into a comprehensive treatment plan that includes counseling and behavioral therapy. This agent is indicated for individuals committed to abstinence, operating under strict medical supervision to ensure both safety and therapeutic efficacy.
Features
- Active Ingredient: Disulfiram
- Pharmacological Class: Aldehyde dehydrogenase inhibitor
- Standard Tablet Strengths: 250 mg and 500 mg
- Administration: Oral, once-daily dosing
- Mechanism: Induces an unpleasant physiological reaction upon alcohol ingestion
- Bioavailability: Well-absorbed from the gastrointestinal tract with slow elimination
- Prescription Status: Available only under medical supervision with a valid prescription
Benefits
- Creates a powerful psychological barrier and negative reinforcement against alcohol consumption by associating it with acutely unpleasant physical effects.
- Supports long-term commitment to sobriety within a structured treatment plan, enhancing the effectiveness of concurrent behavioral therapies.
- Provides a tangible, pharmacological tool that helps patients regain a sense of control over addictive behaviors.
- Reduces the frequency of relapse episodes in motivated patients who are committed to abstinence.
- Functions as a non-addictive, aversive agent, eliminating concerns about substitution dependency.
- Offers a clear, cause-and-effect consequence for alcohol use, which can strengthen personal accountability and treatment adherence.
Common use
Disulfiram is clinically indicated as an adjunctive agent in the management of chronic alcohol use disorder in patients who wish to maintain a state of enforced sobriety. It is not intended for use as a standalone treatment but is most effective when incorporated into a complete therapeutic regimen that includes psychosocial support, counseling, and continuous medical monitoring. It is specifically suited for highly motivated individuals in a stable mental and physical condition who clearly understand and consent to the consequences of alcohol consumption while on the therapy. It is critical that administration is initiated only after the patient has abstained from alcohol for at least 12 hours and is fully aware of the disulfiram-alcohol reaction.
Dosage and direction
Initial dosing must be individualized and initiated under direct medical supervision. A common initiation protocol involves a maximum dose of 500 mg daily for one to two weeks, often administered as a single dose in the morning. Maintenance dosing is typically reduced to 250 mg daily (range 125–500 mg); the minimal effective dose should be determined for each patient. Administration should occur at the same time each day, preferably in the morning, to support regimen adherence. Tablets may be crushed and mixed with liquid if needed. It is imperative that treatment is not started until the patient has been alcohol-free for a minimum of 12 hours and exhibits no signs of intoxication or withdrawal.
Precautions
Disulfiram therapy requires meticulous patient selection and ongoing vigilance. It should not be administered to a patient in a state of alcohol intoxication or without their full knowledge and consent. Baseline and periodic monitoring of liver function tests (transaminases) is mandatory due to the risk of hepatotoxicity. Use with extreme caution in patients with diabetes mellitus, hypothyroidism, epilepsy, cerebral damage, chronic or acute nephritis, hepatic disease or impairment, or cardiovascular disease. Patients must be explicitly warned that the disulfiram-alcohol reaction can occur with any form of alcohol, including that found in sauces, vinegars, cough syrups, tonics, and even topical preparations like aftershave or liniments. The reaction can occur up to 14 days after the last dose of disulfiram due to its long half-life.
Contraindications
Disulfiram is strictly contraindicated in patients with severe myocardial disease or coronary occlusion, psychosis, hypersensitivity to disulfiram or other thiuram derivatives used in pesticides or rubber vulcanization. It is also contraindicated in patients receiving concurrent therapy with alcohol or alcohol-containing preparations, metronidazole, paraldehyde, or any drug that may produce a disulfiram-like reaction. Its use is prohibited in patients who are pregnant, due to potential fetal risk.
Possible side effect
The most significant adverse effect is the disulfiram-alcohol reaction, characterized by flushing, throbbing in head and neck, throbbing headache, respiratory difficulty, nausea, copious vomiting, sweating, thirst, chest pain, palpitations, tachycardia, hypotension, syncope, marked uneasiness, weakness, vertigo, blurred vision, and confusion. In severe cases, respiratory depression, cardiovascular collapse, arrhythmias, myocardial infarction, acute congestive heart failure, unconsciousness, convulsions, and death can occur.
Even in the absence of alcohol, patients may experience side effects including drowsiness, fatigue, impotence, headache, acneiform eruptions, allergic dermatitis, metallic or garlic-like aftertaste, and peripheral neuropathy. Idiosyncratic and hepatotoxic reactions, including hepatitis and hepatic failure, have been reported, typically within the first two months of therapy.
Drug interaction
Extreme caution is required with concomitant medications. Disulfiram inhibits several hepatic enzymes, including aldehyde dehydrogenase (its primary target), dopamine β-hydroxylase, and CYP450 enzymes (notably CYP2E1). This inhibition can significantly increase the plasma concentrations and toxicity of co-administered drugs:
- Warfarin: Potentiates anticoagulant effect; prothrombin time must be monitored closely and warfarin dosage reduced.
- Phenytoin: Increases phenytoin levels, risking toxicity; monitor phenytoin levels.
- Benzodiazepines (e.g., chlordiazepoxide, diazepam): Metabolism may be decreased, potentiating sedative effects.
- Theophylline: Inhibits metabolism, increasing the risk of theophylline toxicity.
- Tricyclic Antidepressants: Metabolism may be inhibited.
- Isoniazid: May increase risk of unsteady gait or significant behavioral changes.
- Metronidazole: Concurrent use is contraindicated due to risk of psychosis or confusional states.
- Any medication containing alcohol (elixirs, syrups) will provoke a disulfiram-alcohol reaction.
Missed dose
If a dose is missed, it should be taken as soon as possible on the same day. However, if it is not remembered until the next day, the missed dose should be skipped. The patient should never double the next dose to make up for a missed one. Consistency in dosing is important for maintaining the enzyme blockade, but a single missed dose does not immediately eliminate the risk of a disulfiram-alcohol reaction, as the drug’s effect persists for an extended period.
Overdose
Symptoms of disulfiram overdose in the absence of alcohol may include nausea, vomiting, dizziness, ataxia, lethargy, seizures, and extrapyramidal symptoms. Neurological symptoms can progress to psychosis, paralysis, and coma. In the event of an overdose, supportive and symptomatic treatment is paramount. Gastric lavage may be considered if performed soon after ingestion. There is no specific antidote. Management involves maintaining respiration and treating shock. If an overdose is accompanied by alcohol ingestion, the resulting disulfiram-alcohol reaction must be treated aggressively as a medical emergency, focusing on supporting cardiovascular and respiratory function.
Storage
Store at controlled room temperature, 20°–25°C (68°–77°F), in a tight, light-resistant container. Keep securely closed and out of reach of children and others for whom it is not prescribed. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational and professional medical reference purposes only and does not constitute medical advice. It is not a substitute for the professional judgment of a qualified healthcare provider based on direct evaluation of an individual patient. The prescriber must review the complete official prescribing information, including boxed warnings, before initiating therapy. Dosage, indications, and safety profiles are subject to change. The patient must be fully informed of the risks and benefits and provide explicit informed consent before treatment begins.
Reviews
“In my addiction psychiatry practice, disulfiram remains a valuable tool for a specific subset of highly motivated patients. Its efficacy is entirely contingent on the patient’s commitment to abstinence, as it provides a powerful psychological ‘fence.’ The key to its successful use is careful patient selection, thorough education, and unwavering adherence to monitoring protocols, particularly for hepatic function.” – Addiction Specialist, 15 years of experience
“The pharmacological deterrence provided by disulfiram is unmatched. However, it demands immense respect from the prescribing clinician. I have seen it be life-changing for patients who fully understand and accept the ‘contract’ it represents. The management of potential drug interactions is a critical part of the pre-prescription workup.” – Clinical Pharmacologist, Academic Medical Center
“While newer medications have emerged, disulfiram’s mechanism of action offers a concrete consequence that some patients need to break the cycle of addiction. It is not a first-line option for everyone, but for the right patient within a structured program, it can be the cornerstone of successful long-term recovery.” – Substance Abuse Counselor, Outpatient Program Director